Bristol-Meyers Squibb Acquires Cardioxyl Pharmaceuticals for $2,075,000,000

  • Feed Type
  • Date
    11/2/2015
  • Company Name
    Cardioxyl Pharmaceuticals
  • Mailing Address
    1450 Raleigh Road Chapel Hill, NC 27517 USA
  • Company Description
    Cardioxyl Pharmaceuticals’ mission is the discovery and development of newclasses of safe and effective therapeutic agents for the treatment ofcardiovascular disease. Cardioxyl’s initial program is a novel medication forthe treatment of acute decompensated heart failure.
  • Website
    http://www.cardioxyl.com
  • Transaction Type
    M&A
  • Transaction Amount
    $2,075,000,000
  • Transaction Round
  • Proceeds Purposes
  • M&A Terms
    The transaction includes upfront and near-term milestone payments of up to $300 million and potential additional consideration of up to $1.775 billion upon the achievement of certain development, regulatory and sales milestones.

Trending on Xconomy